- Home
- CVAC vs QQQX Comparison
CVAC vs QQQX Comparison
Compare CVAC & QQQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- QQQX
- Stock Information
- Founded
- CVAC 2000
- QQQX 2007
- Country
- CVAC Germany
- QQQX United States
- Employees
- CVAC N/A
- QQQX N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- QQQX Finance Companies
- Sector
- CVAC Health Care
- QQQX Finance
- Exchange
- CVAC Nasdaq
- QQQX Nasdaq
- Market Cap
- CVAC 1.2B
- QQQX 1.3B
- IPO Year
- CVAC 2020
- QQQX N/A
- Fundamental
- Price
- CVAC $5.35
- QQQX $27.09
- Analyst Decision
- CVAC Hold
- QQQX
- Analyst Count
- CVAC 3
- QQQX 0
- Target Price
- CVAC $6.83
- QQQX N/A
- AVG Volume (30 Days)
- CVAC 471.1K
- QQQX 127.6K
- Earning Date
- CVAC 11-11-2025
- QQQX 01-01-0001
- Dividend Yield
- CVAC N/A
- QQQX 7.03%
- EPS Growth
- CVAC N/A
- QQQX N/A
- EPS
- CVAC 1.01
- QQQX N/A
- Revenue
- CVAC $599,540,810.00
- QQQX N/A
- Revenue This Year
- CVAC N/A
- QQQX N/A
- Revenue Next Year
- CVAC $23.95
- QQQX N/A
- P/E Ratio
- CVAC $5.32
- QQQX N/A
- Revenue Growth
- CVAC 675.15
- QQQX N/A
- 52 Week Low
- CVAC $2.37
- QQQX $20.27
- 52 Week High
- CVAC $5.72
- QQQX $25.99
- Technical
- Relative Strength Index (RSI)
- CVAC 44.43
- QQQX 51.41
- Support Level
- CVAC $5.32
- QQQX $27.23
- Resistance Level
- CVAC $5.41
- QQQX $27.66
- Average True Range (ATR)
- CVAC 0.04
- QQQX 0.23
- MACD
- CVAC -0.01
- QQQX -0.00
- Stochastic Oscillator
- CVAC 33.33
- QQQX 45.71
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek an attractive total return with less volatility than the Nasdaq 100 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets in an equity portfolio made up of securities comprising the Nasdaq 100 Index (or securities that have economic characteristics that are similar to those securities comprising the Nasdaq 100 Index) that seeks to substantially replicate price movements of the Nasdaq 100 Index and is designed to support the Fund's option strategy.